ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2022

Acylcarnitines: Can They Be Biomarkers of Diabetic Nephropathy?

Xiaodie Mu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.